Ignite Creation Date:
2024-05-06 @ 7:24 AM
Last Modification Date:
2024-10-26 @ 11:47 AM
Study NCT ID:
NCT02521038
Status:
UNKNOWN
Last Update Posted:
2017-10-09
First Post:
2015-08-04
Brief Title:
Use of Ticagrelor in Korean ACS Patients The BRILIANT KOREA Registry
Sponsor:
Organization:
Seoul National University Hospital
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
True
Target Duration:
18 Months
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
SAMPLES_WITHOUT_DNA
Bio Spec Description:
Blood samples for laboratory tests including tests such as CBC electrolyte liver function test BUN creatinine Uric Acid CRP Cholesterol panel etc
Urine samples for Urine Analysis
Enrollment Count:
2000
Enrollment Type:
ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Cohort |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 31336 |
Who Masked List: